hologic discovery w dual energy x ray absorptiometer (Hologic Inc)
86
Structured Review
Hologic Inc
hologic discovery w dual energy x ray absorptiometer
Hologic Discovery W Dual Energy X Ray Absorptiometer, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hologic/absorptiometry+dual+energy+ray+x/pm42280386-123-17-23
Average 86 stars, based on 1 article reviews
Hologic Discovery W Dual Energy X Ray Absorptiometer, supplied by Hologic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hologic/absorptiometry+dual+energy+ray+x/pm42280386-123-17-23
Average 86 stars, based on 1 article reviews
hologic discovery w dual energy x ray absorptiometer - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
Northern Blot:Article Title: Reproductive Factors and Mammographic Density: Associations Among 24,840 Women and Comparison of Studies Using Digitized Film-Screen Mammography and Full-Field Digital Mammography Article Snippet: We studied 24,840 screening-age (40–74 years) non-Hispanic white women who were participants in the Research Program on Genes, Environment and Health of Kaiser Permanente Northern California and underwent Article Title: Dienogest for Treatment of Endometriosis in Women: A 28-Week, Open-Label, Extension Study. Article Snippet: Background: Dienogest provided significantly greater reduction in endometriosis-associated pelvic pain (EAPP) than placebo in a 24-week, randomized, double-blind study of Chinese women with endometriosis.. The current open-label extension study investigated the efficacy and safety of dienogest for 28 additional weeks in this population.. Patients and Methods: Women with endometriosis were eligible to enroll at completion of the 24-week, placebo-controlled study (n = 220). Article Title: Article Snippet: Comparison:Article Title: Reproductive Factors and Mammographic Density: Associations Among 24,840 Women and Comparison of Studies Using Digitized Film-Screen Mammography and Full-Field Digital Mammography Article Snippet: We studied 24,840 screening-age (40–74 years) non-Hispanic white women who were participants in the Research Program on Genes, Environment and Health of Kaiser Permanente Northern California and underwent Article Title: Dienogest for Treatment of Endometriosis in Women: A 28-Week, Open-Label, Extension Study. Article Snippet: Background: Dienogest provided significantly greater reduction in endometriosis-associated pelvic pain (EAPP) than placebo in a 24-week, randomized, double-blind study of Chinese women with endometriosis.. The current open-label extension study investigated the efficacy and safety of dienogest for 28 additional weeks in this population.. Patients and Methods: Women with endometriosis were eligible to enroll at completion of the 24-week, placebo-controlled study (n = 220). Article Title: Article Snippet: |